AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 62(4), 2000, pp. 466-479
Copyright © 2000 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, W.
Right arrow Articles by Saul, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, W.
Right arrow Articles by Saul, A
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 62, Issue 4, 466-479
Copyright © 2000 by American Society of Tropical Medicine and Hygiene

Research Articles


Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys

WE Collins, A Walduck, JS Sullivan, K Andrews, A Stowers, CL Morris, V Jennings, C Yang, J Kendall, Q Lin, LB Martin, C Diggs, and A Saul

A vaccine trial was conducted with rhoptry-associated proteins 1 and 2 (RAP1 and RAP2) of Plasmodium falciparum in Saimiri boliviensis monkeys to compare the ability of parasite-derived (PfRAP1 and 2) and recombinant proteins (rRAP1 and 2) to induce protective immune responses and to find adjuvants suitable for use in humans. Eight groups of 6 monkeys each were immunized with parasite-derived or recombinant RAP1 and 2 with Freund's complete adjuvant (FCA) followed by Freund's incomplete adjuvant (FIA), Montanide ISA720 adjuvant, or CRL1005 adjuvant. Recombinant RAP1 and RAP2 were also administered separately, with Montanide ISA720. After 3 immunizations, monkeys were challenged by iv inoculation of 50,000 parasites of the Uganda Palo Alto strain of P. falciparum. Of the animals vaccinated using FCA/FIA, 1 of 6 control monkeys, 3 of 6 immunized with PfRAP1 and 2, and 2 of 6 with rRAP1 and 2 did not require drug treatment. Of the monkeys vaccinated with Montanide ISA720 adjuvant, 0 of the 6 control monkeys, 2 of 6 immunized with RAP1 and 2, 1 of 6 immunized with rRAP1, and 4 of 6 immunized with RAP2 did not require drug treatment. Two of 6 monkeys immunized with PfRAP1 and 2 with CRL1005 did not require treatment. All groups receiving RAP1, RAP2, or both had a significant decrease in initial parasite multiplication rates and there was a significant negative correlation between anti-RAP2 antibody and multiplication rates. Animals were rechallenged with the homologous parasite 126 days after the first challenge. Of the monkeys that did not require drug treatment after the first challenge, none developed detectable parasitemia following rechallenge.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
W. E. COLLINS, G. G. GALLAND, J. W. BARNWELL, V. UDHAYAKUMAR, J. S. SULLIVAN, D. NACE, J. E. TONGREN, T. WILLIAMS, J. ROBERTS, Y. P. SHI, et al.
PRELIMINARY OBSERVATIONS ON THE EFFICACY OF A RECOMBINANT MULTISTAGE PLASMODIUM FALCIPARUM VACCINE IN AOTUS NANCYMAI MONKEYS
Am J Trop Med Hyg, October 1, 2005; 73(4): 686 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. S. SULLIVAN, J. J. SULLIVAN, A. WILLIAMS, K. K. GRADY, A. BOUNNGASENG, C. S. HUBER, D. NACE, T. WILLIAMS, G. G. GALLAND, J. W. BARNWELL, et al.
ADAPTATION OF A STRAIN OF PLASMODIUM FALCIPARUM FROM GHANA TO AOTUS LEMURINUS GRISEIMEMBRA, A. NANCYMAI, AND A. VOCIFERANS MONKEYS
Am J Trop Med Hyg, December 1, 2003; 69(6): 593 - 600.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
S. Mahanty, A. Saul, and L. H. Miller
Progress in the development of recombinant and synthetic blood-stage malaria vaccines
J. Exp. Biol., November 1, 2003; 206(21): 3781 - 3788.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Birkett, K. Lyons, A. Schmidt, D. Boyd, G. A. Oliveira, A. Siddique, R. Nussenzweig, J. M. Calvo-Calle, and E. Nardin
A Modified Hepatitis B Virus Core Particle Containing Multiple Epitopes of the Plasmodium falciparum Circumsporozoite Protein Provides a Highly Immunogenic Malaria Vaccine in Preclinical Analyses in Rodent and Primate Hosts
Infect. Immun., December 1, 2002; 70(12): 6860 - 6870.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society of Tropical Medicine and Hygiene.